Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3730888
Max Phase: Preclinical
Molecular Formula: C16H28O
Molecular Weight: 236.40
Molecule Type: Small molecule
Associated Items:
ID: ALA3730888
Max Phase: Preclinical
Molecular Formula: C16H28O
Molecular Weight: 236.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CO[C@]1(C)CC[C@H]2C(C)(C)[C@@H]3C[C@@]21CC[C@H]3C
Standard InChI: InChI=1S/C16H28O/c1-11-6-9-16-10-12(11)14(2,3)13(16)7-8-15(16,4)17-5/h11-13H,6-10H2,1-5H3/t11-,12-,13+,15-,16+/m1/s1
Standard InChI Key: XSHVEMOQIUUEQH-QUEVPRLRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 236.40 | Molecular Weight (Monoisotopic): 236.2140 | AlogP: 4.26 | #Rotatable Bonds: 1 |
Polar Surface Area: 9.23 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.91 | CX LogD: 3.91 |
Aromatic Rings: 0 | Heavy Atoms: 17 | QED Weighted: 0.66 | Np Likeness Score: 2.87 |
1. (2013) Agent for inhibiting odor of pyrazine derivatives, |
Source(1):